Benchmark raised the firm’s price target on Marcus (MCS) to $25 from $22 and keeps a Buy rating on the shares. After having recently concluded a non-deal roadshow with the executive team, the firm believes the company’s theatrical segment is poised to be a key area of growth in the coming years, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue